Snyder T N,Madhavan K,Intrator M,et al. A fibrin/hyaluronic acid hydrogel for the delivery of mesenchymal stem cells and potential for articular cartilage repair[J]. J. Biol. Eng.,2014,8:10-21.
Platt V M,Szoka F C Jr. Anticancer therapeutics:Targeting macromolecules and nanocarriers to hyaluronan or CD44,a hyaluronan receptor[J]. Mol. Pharm.,2008,5(4):474-486.
[8]
Yadav A K,Mishra P,Agrawal G P. An insight on hyaluronic acid in drug targeting and drug delivery[J]. J. Drug Target,2008,16(2):91-107.
[9]
Tian H,Lin L,Chen J,et a1. RGD targeting hyaluronic acid coating system for PEI-PBLG polycation gene carriers[J]. J. Controlled Release,2011,155:47-53.
[10]
Park S,Bhang S H,La W G,et a1. Dual roles of hyaluronic acids in muhilayer films capturing nanocarriers for drug-eluting coatings[J]. Biomaterials,2012,33:5468-5477.
[11]
Picaud L,Thibault B,Mery E,et al. Evaluation of the effects of hyaluronic acid-carboxymethyl cellulose barrier on ovarian tumor progression[J]. J. Ovarian Res.,2014,7:40-52.
[12]
Luo Y,Ziebell M R,Prestwich G D.A hyaluronic acid-taxol antitumor bioconjugate targeted to cancer cells[J]. Biomacromolecules,2000,1(2):208-218.
Vasi A M,Popa M I,Butnaru M,et al. Chemical functionalization of hyaluronic acid for drug delivery applications[J]. Mater. Sci. Eng. C,2014,38:177-185.
Saravanakumar G, Choi K Y,Yoon H Y. Hydrotropic hyaluronic acid conjugates:Synthesis,characterization,and implications as a carrier of paclitaxel[J]. Int. J. Pharm.,2010,394:154-161.
[23]
Cho H J,Yoon I S,Yoon H Y. Polythylene glycol-conjugated hyaluronic acid-ceramide self-assembled nanoparticles for targeted delivery of doxorubicin[J]. Biomaterials,2012,33:1190-1200.
[24]
Goodarzi N,Ghahremani M H,Amini M,et al. CD44-targeted docetaxel conjugate for cancer cells and cancer stem-like cells:A novel hyaluronic acid-based drug delivery system[J]. Chem. Biol. Drug Des.,2014,83:741-752.
